BECN1 and glioma: Experimental blockade of dipeptidyl peptidase 4 (DPP4), otherwise known as a stem cell marker, led to an inhibition of the autophagic Beclin1 pathway and to an enhancement of TMZ-induced cytotoxicity in glioma cells.